Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer

Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer

Kyriaki Pistevou-Gompaki1, Apostolos Hatzitolios2, Nikos Eleftheriadis2, Evaggelos Boultoukas2, George Ntaios2, Ioannis Andronikidis2, Ioannis Tzitzikas11Department of Radiation Oncology; 2First Propedeutic Department of Internal Medicine, AHEPA Hospital, Aristotle University, Thessaloniki, GreeceIn...

Full description

Bibliographic Details
Main Authors:	Kyriaki Pistevou-Gompaki, Apostolos Hatzitolios, Nikos Eleftheriadis, Evaggelos Boultoukas, George Ntaios, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-10-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/evaluation-of-cardiotoxicity-five-years-after-2d-planned-non-simulated-a2331

Similar Items

Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?
by: Kiki Pistevou-Gompaki, et al.
Published: (2008-01-01)

Long-term radiotherapy related complications in children with head and neck cancer: Another era for pediatric oncologic pathology
by: Nikolaos Eleftheriadis, et al.
Published: (2009-03-01)

Long term chemoradiotherapy-related dental and skeletal complications in a young female with nasopharyngeal carcinoma
by: Ioulia Ioannidou-Marathiotou, et al.
Published: (2010-06-01)

Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?
by: Kiki Pistevou-Gompaki M.D., et al.
Published: (2008-01-01)

Radiation induced cardiotoxicity in left sided breast cancer - Where do we stand?
by: Pamela Alice Kingsley, et al.
Published: (2015-01-01)

Homocysteine and carotid intima-media thickness in ischemic stroke patients are not correlated
by: George Ntaios, et al.
Published: (2008-04-01)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
by: Mutlay Sayan, et al.
Published: (2019-10-01)

Oxidative Stress in Radiation-Induced Cardiotoxicity
by: Zhang Ping, et al.
Published: (2020-01-01)

Left Ventricular Regional Wall Motion Abnormality is a Strong Predictor of Cardiotoxicity in Breast Cancer Patients Undergoing Chemotherapy
by: Márcio Vinícius Lins de Barros, et al.
Published: (2018-12-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Cardiotoxicity as undesired side effect in the treatment of breast cancer
by: Michalina Gramatyka
Published: (2014-05-01)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
by: Cochera F, et al.
Published: (2018-07-01)

Trastuzumab Related Cardiotoxicity in Taiwanese Breast Cancer Women
by: Hsu-ChihChien, et al.
Published: (2016)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
by: Valentina K Todorova, et al.
Published: (2016-01-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Dosimetric Comparison of Radiation Techniques for Comprehensive Regional Nodal Radiation Therapy for Left-Sided Breast Cancer: A Treatment Planning Study
by: Heejoo Ko, et al.
Published: (2021-04-01)

Optimization of Heart Block in the Left-sided Whole Breast Radiation Treatments
by: Ning Jeff Yue, et al.
Published: (2014-12-01)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Carbamazepine Cardiotoxicity
by: J Gordon Millichap
Published: (1993-10-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Imaging of Cardiotoxicity
by: Jerry D. Glickson, et al.
Published: (2008-05-01)

Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients
by: Wei Hao MD, et al.
Published: (2020-07-01)

Usefulness of Myocardial Deformation Indices in Preventing Cardiotoxicity in Breast Cancer Patients
by: Marcelo Dantas Tavares de Melo, et al.

Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
by: PLOS ONE Editors
Published: (2019-01-01)

Cardiotoxicity of Pertuzumab Containing Regimens for HER-2 Positive Breast Cancer
by: Lin, Michelle, et al.
Published: (2017)

Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer
by: Krikeli M, et al.
Published: (2011-07-01)

Erratum
by: Krikeli M, et al.
Published: (2011-12-01)

Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients?
by: Juanqi Wang, et al.
Published: (2017-05-01)

Comorbidity of cardiovascular diseases and cancers: Problems in the diagnosis of cardiotoxic effects of chemo- and radiation therapy
by: I E Chazova, et al.
Published: (2015-09-01)

RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS
by: V. I. Chernov, et al.
Published: (2016-12-01)

Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment
by: Robyn A. Clark, et al.
Published: (2017-10-01)

Right Ventricular Dysfunction in Patients Experiencing Cardiotoxicity during Breast Cancer Therapy
by: Anna Calleja, et al.
Published: (2015-01-01)

Cardiac troponin T for early detection of cardiotoxicity in breast cancer patients treated with epirubicin
by: Erdim Refik, et al.
Published: (2009-09-01)

About the article “Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients”
by: Elia de la Caridad Rodríguez-Venegas, et al.
Published: (2020-04-01)

Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity
by: Rebecca K. Hoffman, et al.
Published: (2021-04-01)

Cardioprotection From Cardiotoxicity
by: Guilherme H. Oliveira, MD, MBA
Published: (2019-09-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Osimertinib-Induced Cardiotoxicity
by: Kartik Anand, MD, et al.
Published: (2019-12-01)